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Antimicrobial peptides (AMPs) are natural compounds isolated from a wide variety of
organisms that include microorganisms, insects, amphibians, plants, and humans. These
biomolecules are considered as part of the innate immune system and are known as
natural antibiotics, presenting a broad spectrum of activities against bacteria, fungi, and/or
viruses. Technological innovations have enabled AMPs to be utilized for the development
of novel biodetection devices. Advances in nanotechnology, such as the synthesis of
nanocomposites, nanoparticles, and nanotubes have permitted the development of nanos-
tructured platforms with biocompatibility and greater surface areas for the immobilization
of biocomponents, arising as additional tools for obtaining more efﬁcient biosensors.
Diverse AMPs have been used as biological recognition elements for obtaining biosensors
with more speciﬁcity and lower detection limits, whose analytical response can be
evaluated through electrochemical impedance and ﬂuorescence spectroscopies. AMP-
based biosensors have shown potential for applications such as supplementary tools for
conventional diagnosis methods of microorganisms. In this review, conventional methods
for microorganism diagnosis as well new strategies using AMPs for the development of
impedimetric and ﬂuorescent biosensors are highlighted. AMP-based biosensors show
promise as methods for diagnosing infections and bacterial contaminations as well as
applications in quality control for clinical analyses and microbiological laboratories.
Keywords: antimicrobial peptides, biosensors, bacterial infections, impedance spectroscopy, fluorescence
spectroscopy
ANTIMICROBIAL PEPTIDES
Currently, the search for novel compounds with antibiotic ability
to overcome bacterial resistance has increased. Antimicrobial pep-
tides (AMPs) appear to be an excellent alternative, since more
effective therapeutic approaches are required for many types
of pathogens (Brogden et al., 2005; Hancock and Sahl, 2006;
Schmidtchen et al., 2014). AMPs are components of the innate
immune system, acting in defense against multiple pathogens
(Schmidtchen et al., 2014). In general, AMPs may also show other
different activities such as antiviral or antitumor properties, mak-
ing them excellent candidates as new therapeutic drugs (Reddy
et al., 2004).
Antimicrobial peptides are biomolecules present in diverse
organisms, such as insects, plants, and animals (Mendez et al.,
1990; Schnapp and Harris, 1998). In general, AMPs are mainly
cationic small molecules composed of 10–50 amino acids residues
in length, with molecular masses ranging from 1 to 5 kDa. In addi-
tion, AMPs comprise a chemically and structurally heterogeneous
family (Andreu and Rivas, 1998; Costa et al., 2011).
In general, AMPs only assume an amphipathic structure
after interacting with the bacterial membrane, since it is
not a favorable structure in an aqueous environment, allow-
ing lethal permeabilization of the bacterial membrane (van’t
Hof et al., 2001; Costa et al., 2011). The classical modes of
action described previously in the literature are not neces-
sarily exclusive of one other (van’t Hof et al., 2001; Brogden
et al., 2005; Toke, 2005; Bechinger and Lohner, 2006). In
the case of the barrel-stave model, a lipid bilayer disruption
by AMPs occurs, until the peptides reach a threshold con-
centration and insert themselves across the bilayer to obtain
peptide-lined pores. Subsequently, a membrane solubilization
into micellar structures occurs, resulting in the carpet model or
in forming peptide-and-lipid lined pores (toroidal pore model;
Rapaport and Shai, 1991).
The mechanisms of action of AMPs (Figure 1) were reviewed
and described by Nguyen et al. (2011). In this new proposal,
pore formation in the disordered toroidal pore model is more
stochastic, involving low peptide quantity. The presence of pep-
tides can directly affect the bilayer thickness and, therefore, the
membrane is remodeled to form rich domains of anionic lipids
on the peptide surface. In addition, AMPs can form non-bilayer
intermediates in the membrane coupled to small anions. On the
other hand, in the molecular electroporation model, a peptide
accumulation occurs on the outer lipid membrane leaﬂet, mak-
ing the membrane permeable to various molecules including the
AMPs (Nguyen et al., 2011).
Nanotechnology has been widely introduced for multidisci-
plinary applications, especially associated with the use of AMPs
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FIGURE 1 | Schematic diagram summarizing the possible mechanisms
of peptide–membrane interaction. (A) Barrel-stave model: the peptide
assumes an amphipathic helical conformation and organizes itself to form
a structure with a central lumen, like a barrel. The hydrophobic part of the
AMP interacts with the lipid acyl chains of the membrane and their
hydrophilic part is exposed so as to form the lumen of the transmembrane
aqueous channel. (B) Carpet model: cationic peptides are attracted by
anionic phospholipids covering the surface of the bacterial membrane until
reaching a saturation point, resulting in solubilization of the bacterial
membrane. (C) Toroidal model: the peptide helices are inserted parallel to
the membrane and cause folding of the lipid monolayers in order to form
a pore formed by peptides interspersed with phospholipids. In this model,
an association between polar peptide groups with the lipid polar head
groups is established. (D) Detergent model: membrane solubilization
occurs, leading to formation of micellar structures, resulting in the
destabilization of the lipid membrane and cell death.
in biology and biomedicine (Barkalina et al., 2014). Among the
diverse uses of AMPs have been highlighted quality controls of
foods, raising animals, controlled release systems and biosensors
(Li et al., 2012; Sobczak et al., 2013). In this context, the pep-
tide nisin has been applied as a milk-derived preservative for
quality control in foods (Bi et al., 2011). In animal husbandry,
peptides can be used in ruminants as an alternative to common
antibiotics, avoiding bacterial resistance or assisting in the immu-
nization of animals for the prevention of diseases (Cheema et al.,
2011).
Infectious diseases have been part of humanity for centuries,
some of them killing millions of people worldwide. Different
types of pathogens (bacteria, viruses, fungi, and parasites) can
cause infections from either exogenous (acquired from the envi-
ronment, animals, or people) or endogenous (from the normal
ﬂora) origins (Mazzoni et al., 1987; Murthy et al., 2013). Further-
more, in agribusiness, the use of puriﬁed peptides, as well as the
development of transgenic plants, aims tominimize plant diseases,
avoiding the use of fungicides (Keymanesh et al., 2009). In clinical
applications, some AMPs are in the early stages of clinical research
to prevent inﬂammation and sepsis (Schuerholz et al., 2012).
Identiﬁcation and quantiﬁcation of pathogenic agents are two
important parameters for the diagnosis of bacterial infections and
the implementation of effective drug therapy (Lazcka et al., 2007).
The most common methods are direct examination by counting
bacterial colonies in culture plates and serodiagnosis tests (van Pelt
et al., 1999). Direct examination by optical microscopy can iden-
tify the morphology using a simple and speciﬁc Gram staining.
Culture media allow the growth as well as the isolation and identi-
ﬁcation of speciﬁc types of bacteria (Szakal and Pal, 2003; Bragulat
et al., 2004). However, these methods are time-consuming and
require specialized technicians. Of note, it may require weeks to
obtain a correct diagnosis of some pathogens from samples of
mucosa, skin, or blood (Benes et al., 1996). Unfortunately, a few
days may be sufﬁcient to signiﬁcantly worsen the clinical status of
the patient before receiving appropriate treatment.
Traditional methods of diagnosis also consist of molecular
tests or nucleic acid ampliﬁcation test (NAAT). Techniques based
on NAAT include polymerase chain reaction (PCR), ligase chain
reaction, transcription mediated ampliﬁcation, strand displace-
ment ampliﬁcation, and loop-mediated isothermal ampliﬁcation
(Andersen et al., 2000; Yang et al., 2002; Palka-Santini et al., 2009).
Techniques based on nucleic acids enable speciﬁc molecular detec-
tion through hybridization between a DNA molecule and its
complementary strand (Junhui et al., 1997; Wang et al., 1997;
Wang, 1998). Although effective, these techniques may present
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some limitations, such as the need for sample enrichment and
puriﬁcation prior to analysis, prolonged experimentation time,
false-positive results due to cross-reactions, and high cost (Caygill
et al., 2010; Singh et al., 2014).
In order to reduce or overcome these restrictions, newdetection
methods are required, and biosensors are considered promising
tools for clinical diagnosis (Abdel-Hamid et al., 1999; Deisingh
and Thompson, 2004). In this context, AMPs can be an excel-
lent alternative for the development of biosensors, since their
potential use for speciﬁc detection of pathogenic bacteria has been
demonstrated (Kulagina et al., 2005).
STRATEGIES FOR THE DEVELOPMENT OF AMP-BASED
BIOSENSORS
Advances innanotechnologyhave contributed to the improvement
of biotechnological research associated with the rapid progres-
sion of biodetection devices (Jianrong et al., 2004; Fournier-Wirth
and Coste, 2010; Yeom et al., 2011). Nanostructures have been
extensively used in the biosensor development due to their unique
physicochemical characteristics such as quantum size effect, ele-
vated ratio between surface area and volume, and analytical signal
ampliﬁcation capacity (Jianrong et al., 2004; Li et al., 2010). The
utilization of AMPs as recognition elements in biosensors is a rela-
tively new concept, but their development is of great relevance due
to numerous potential areas for application (Etayash et al., 2014).
Biosensors are chemical devices comprising two basic func-
tional units (Figure 2). The ﬁrst one is a biomolecule responsible
for recognition of the target substance through speciﬁc inter-
molecular binding or by means of catalytic reactions (D’Orazio,
2003). The second is the transducer that converts the bio-
chemical response into a measurable electric signal, which is
mainly proportional to analyte concentration (Higgins and Lowe,
1987; Hulanicki et al., 1991; Thévenot et al., 2001). In addition,
diverse transducers can be used for conversion of the biochemi-
cal response into a quantiﬁable analytical signal, being classiﬁed
according to their physical principles as electrochemical, electri-
cal, optical, piezoelectric, calorimetric, acoustic, and magnetic
(Hulanicki et al., 1991; Sethi, 1994; Marco and Barcelo, 1996;
Thévenot et al., 2001).
Electrochemical impedance spectroscopy (EIS) comprises the
current main strategy used for the development of biodevices
based on AMPs, as shown in Table 1. EIS is an effective method
for the investigation of modiﬁed surfaces and monitoring of inter-
facial processes, allowing the characterization of electrochemical
systems (Stoynov and Savova-Stoynova, 1986; Bard and Faulkner,
2000; Lasia, 2002). In the EIS technique, a signal of perturba-
tion of low amplitude, in the form of sinusoidal potential and
different frequency values, is applied to the transducer, form-
ing sinusoidal alternating current (Macdonald, 1990, 1992; Katz
and Willner, 2003; Chang and Park, 2010). EIS is a valuable
tool for interfacial phenomena analyses occurring between elec-
trode and solution. Dielectric analyses allows for the evaluation
of electron charge-transfer parameters, double-layer, electrical
layer, and modeling the experimental data to equivalent circuits
(Stoynov and Savova-Stoynova, 1986; Macdonald, 1990; Bott,
2001; Oliveira et al., 2011). EIS is a technique of great relevance due
to numerous technological applications such as the development
of biosensors, studies of dielectric materials, corrosion processes,
biofuel cells and rechargeable batteries (Macdonald, 1992; Guan
et al., 2004). EIS is a new experimental approach for under-
standing AMP mechanisms of action through lipid membrane
properties by monitoring changes such as thickness, ion per-
meability and homogeneity after peptide exposure (Chang et al.,
2008; Oliveira et al., 2011; Nascimento et al., 2012; Sugihara et al.,
2012).
Several biological elements can be used for the manufacturing
of biosensitive systems, such as cell receptors, enzymes, antibodies,
antigens, nucleic acids, aptamers, lectins, and peptides (Byﬁeld
and Abuknesha, 1994; Guan et al., 2004; Caygill et al., 2010). In
particular, AMPs are outstanding molecules due to their wide
biotechnological applications (Dawson and Liu, 2008; Meng et al.,
2010; Seo et al., 2012). In addition, AMPs are promising molecules
for the development of biosensors due to the possibility of rec-
ognizing a wide variety of pathogenic agents, including bacteria,
FIGURE 2 | Schematic presentation of an electrochemical biosensor.The
detection of the analyte (A) is performed through a biological component
(B) associated to a transducer (C). This is responsible for converting the
biochemical response arising from the biospeciﬁc interaction into an electrical
signal (D) which will be ampliﬁed and processed by a computer software
(E) which will describe, through graphs (F), the bioactivity of the system.
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Table 1 | Antimicrobial peptides, their immobilization substrates and molecular targets with the respective detection limits obtained through
different techniques.
AMPs Substrate immobilization Target recognition Detection limit Technique Reference
Magainin I Gold surface – lipoic acid
N -hydroxysuccinimide –
ferrocene
Escherichia coli
O157:H7
103 CFU ·mL−1 Electrochemical impedance Li et al. (2014)
Magainin I Glass microbeads –
N -[γ-maleimidobutyryloxy]
succinimide ester (GMBS) –
cysteine
Non-pathogenic
Escherichia coli
103 cells ·mL−1 Fluorescence microscopy Yoo et al. (2014)
Magainin I Gold surface – cysteine Salmonella
typhimurium
103 CFU ·mL−1 Electrical impedance Mannoor et al. (2010)
Leucocin A Gold surface – cysteamine Listeria
monocytogenes
103 CFU ·mL−1 Electrical impedance Etayash et al. (2014)
Bactenecin Glass slide –
3-mercaptopropyl
triethoxysilane (MPTES) –
GMBS
Brucella melitensis
Vaccinia virus
Venezuelan equine
encephalitis virus
Coxiella burnetti
5 × 104 cells ·mL−1
<5 × 105 PFU ·mL−1
<5 × 105 PFU ·mL−1
5 × 105 cells ·mL−1
Fluorescence spectroscopy Kulagina et al. (2007)
G10KHc Gold surface – cysteine Pseudomonas
aeruginosa
105 CFU ·mL−1 Electrical impedance Lillehoj et al. (2014)
C16G2cys Gold surface – cysteine Streptococcus
mutans
105 CFU ·mL−1 Electrical impedance Lillehoj et al. (2014)
Cecoprin A Glass slide – poly(dimethyl)
siloxane (PDMS)
Botulinum toxin A 1 ng ·mL−1 Fluorescence spectroscopy Kulagina et al. (2006)
Melittin Glass slide – PDMS Botulinum toxin B 10 ng ·mL−1 Fluorescence spectroscopy Kulagina et al. (2006)
*CFU, colony forming units; PFU, plaque forming units.
fungi, toxins, and viruses with lipoprotein envelope (Zasloff, 2002;
De Smet and Contreras, 2005; Kulagina et al., 2007).
The basic principle that enables the use of AMPs in biosen-
sors is its ability to selectively interact with the cell membrane
components of pathogens (Kulagina et al., 2005). The (bio) inter-
action is mainly driven by electrostatic forces, hydrogen bonds,
and hydrophobic interactions (Seelig, 2004). Biological recogni-
tion thermodynamics depends on lipid membrane composition
and peptide properties such as hydrophobicity, amphipathic-
ity, molecular charge, and degree of secondary structure angle
(Mozsolits et al., 2001; Papo and Shai, 2003; Fernandes et al., 2012;
Oliveira et al., 2013). Therefore, AMP speciﬁcity is based on the
different molecular afﬁnities, allowing their employment in diag-
nostic tests (Kulagina et al., 2005; Etayash et al., 2014; Li et al.,
2014).
Interdigitated electrodes are an excellent alternative for biosen-
sor development. Mannoor et al. (2010) reported the develop-
ment of an interdigitated capacitive biosensor for detection of
Escherichia coli and Salmonella typhimurium. In this study, maga-
inin I was immobilized on gold microelectrodes via its C-terminal
cysteine residue, and the binding capacity to bacterial cells was
evaluated by EIS. The changes in the dielectric properties of the
modiﬁed electrode surface allowed the determination of selectivity
for pathogenic Gram-negative bacteria E. coli and Salmonella
typhimurium in relation to non-pathogenic E. coli and the Gram-
positive species Listeria monocytogenes (Mannoor et al., 2010).
Recently, Li et al. (2014) developed an impedimetric biosensor
with magainin I conjugated to a structured ﬁlm of ferrocene for
bacterial detection. The biosensor showed a preferential selectivity
for E. coli O157: H7 followed by non-pathogenic E. coli K12,Bacil-
lus subtilis and Staphylococcus epidermidis. In addition, a detection
limit was observed for E. coli O157: H7 of 103 CFU mL−1.
A microelectromechanical sensor using two synthetic peptides
(C16G2cys orG10KHc)wasdeveloped for thedetectionof Strepto-
coccusmutans andPseudomonas aeruginosa (Lillehoj et al., 2014).It
is important to note that C16G2cys and G10KHc have a cysteine
amino acid residue in the C-terminus, and the -SH group of the
cysteine can be used to promote binding on the gold surface,
resulting in the vertical orientation of the recognition molecules.
Among the optical properties explored for the construction of
biosensors, one of the most prevalent is ﬂuorescence, evaluated
by a signiﬁcant number of techniques that allow the analysis of
the systems conjugated with ﬂuorophores and molecular targets
quantiﬁcation (Gauglitz, 2005; Altschuh et al., 2006; Lazcka et al.,
2007; Fan et al., 2008). Fluorescence is a phenomenon of photon
emissions, resulting from the passage of a valence electron in
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an orbital of ground state to an orbital of higher energy to the
absorption of radiation of appropriate wavelength. Upon return-
ing to the state of origin, photons are liberated with bottom
energy to absorbed light. Fluorescence spectroscopy allows for
the quantiﬁcation of the analyte with sensibility, low cost, and
easy implementation (Eaton, 1990; Lazcka et al., 2007). Thus, the
molecular recognition is assessed through variations in ﬂuores-
cence properties after the interaction of the bioreceptor with the
speciﬁc target (McFarland and Finney, 2001; Altschuh et al., 2006).
In this context, magainin I was immobilized on glass slides
modiﬁed with 3-mercaptopropyl triethoxysilane (MPTES) and
N-(γ-maleimidobutyryloxy) succinimide ester (GMBS) through
direct covalent binding or by avidin–biotin coupling, being used
as a recognition molecule for E. coli O157: H7 and Salmonella
typhimurium (Kulagina et al., 2005). The immobilization method
interferes with biosensor sensitivity, and the direct binding of
magainin I reduces non-speciﬁc interactions, resulting in detec-
tion limits of 1.6 × 105 and 6.5 × 104 cells mL−1 for E. coli and
Salmonella typhimurium labeled with Cy5, respectively. Through
the indirect method values of 6.8 × 105 and 5.6 × 105 cells
mL−1 were obtained (Kulagina et al., 2005). Moreover, cecropin
A, parasin, magainin I, and polymyxin B and E, immobilized
on a glass slide modiﬁed with MPTES and GMBS, were also
used in screening ﬂuorescent assays for detection of E. coli
O157:H7 and Salmonella typhimurium (Kulagina et al., 2006).
The assay in “sandwich” format, with the employment of Cy3-
labeled anti-E. coli or anti-Salmonella, demonstrated different
AMP afﬁnities for pathogenic species (Kulagina et al., 2006). In
another study, cecropin (A, B, and P), parasin, magainin I,
polymyxin (B and E), melittin, and bactenecin were evaluated
for the biodetection of viral particles and bacterial cells using Cy3
(Kulagina et al., 2007).
Cecropin P1 (CP1), SMAP-29, and PGQ were used as alter-
native molecules for detection of E. coli O157:H7 in substitution
of the anti-E. coli O157:H7 antibody (Arcidiacono et al., 2008).
Through screening in solution and quantiﬁcation of ﬂuorescence,
it was veriﬁed that the detection limits forCy5CP1,Cy5 SMAP,and
Cy5 PGQ were 104, 105 e106 CFU mL−1, respectively, in compari-
son to 105 CFU mL−1 for Cy5 anti-E. coli O157 antibody. Because
of the high sensitivity of the CP1 and speciﬁcity of the anti-E. coli
O157:H7 antibody, a prototype immuno-magnetic bead biosensor
was developed, resulting in a 10-fold improvement in sensitivity
(Arcidiacono et al., 2008).
Glass microspheres (GMs) based on microﬂuidic chip were
used for magainin I immobilization as a new method for
E. coli biodetection (Yoo et al., 2014). GMs provided greater
detection efﬁciency through the increase of superﬁcial area of
adsorption relative to the volume, enabling a greater number
of bonds between microorganism-AMPs. The biodevice pre-
sented a good detection efﬁciency of 87% in a limit of 103 cells
mL−1 obtained by image analysis under ﬂuorescence microscopy
(Yoo et al., 2014).
The most common application of AMP-based biosensors is
the identiﬁcation of diverse bacteria such as E. coli, Salmonella
typhimurium, L. monocytogenes, Streptococcus mutans, P. aerug-
inosa, and others (Mannoor et al., 2010; Li et al., 2014). In this
scenario,AMPs stand out for presenting differential characteristics
and large applicability potential, since AMPs are highly stable
under unsuitable conditions and can be continuously exposed to
natural surroundings (Casteels et al., 1989; Mannoor et al., 2010;
Laverty et al., 2011; Hassan et al., 2012; Dawgul et al., 2014). AMPs
are capable of interacting with invariant components of the target
surfaces (Kulagina et al., 2006), providing each peptide with the
possibility of recognizing a variety of pathogens (Zasloff, 2002;
De Smet and Contreras, 2005; Kulagina et al., 2007). Despite the
importance of bacterial diagnosis, diverse studies have undertaken
to develop detection systems for other microorganisms and tox-
ins (Zasloff, 2002; De Smet and Contreras, 2005; Kulagina et al.,
2007).
Therefore, AMPs can be used in nanostructured platforms for
the detection of pathogenic agents due to their singular properties,
ease of acquisition, and relevant biological activity (Kulagina et al.,
2005; Yonekita et al., 2013). AMPs are an excellent alternative for
obtaining new, sensitive, inexpensive, portable, versatile, and fast
methods of diagnostics for analyte identiﬁcation and quantiﬁca-
tion (Caygill et al., 2010; Yoo et al., 2014). Thus, nanobiosensors
based on AMPs can be used in basic and applied research, clinical
analysis, commercial applications, microbiological quality con-
trol, and environmental monitoring (Higgins and Lowe, 1987;
D’Orazio, 2003; Mehrvar and Abdi, 2004).
CONCLUSION
Antimicrobial peptides are considered promising molecules in
the development of biodetection devices. Nanotechnology has
enabled the construction of biosensors based on AMPs with
more speciﬁcity and sensitivity for detection of pathogenic agents.
Biosensors based on AMPs are a useful tool since it is possible to
investigate a wide variety of molecular targets in real time, provid-
ing quantitative or semi-quantitative analytical information that is
both speciﬁc and selective. In spite of AMP-based biosensors being
prototypes and their remaining challenges to commercialization
such as reproducibility, validation and proper standardization,
they may be considered valuable alternatives for obtaining new
diagnostic methods.
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